Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician
Interrupter Ultra Serum, a complement to its A.G.E
The bottom line The Wegovy pill is the first oral GLP-1 weight-loss tablet you can actually get in the UK, and it edges Foundayo on average trial weight loss (around 13.6% vs 11.2%)
Patients should not assume these products are safe, legal, accurately dosed, sterile, or appropriate for human use
USA 89 , 86418645 (1992)
Patients should intentionally hydrate , aiming for adequate daily fluid intake consistent with national hydration guidelines , adjusted for body size and activity. Key point: Fiber without adequate fluid intake can worsen constipation by increasing stool bulk without improving passage